The House Concurrent Resolution No. by Representative Turner calls on the United States Congress to take decisive action to address the detrimental practices of pharmacy benefit managers (PBMs) that significantly impact the pricing, availability, and distribution of prescription medications. PBMs, which manage drug benefits for health insurers and government programs, have been criticized for contributing to rising drug costs, lack of transparency, and restrictive formularies that limit patient access to necessary medications. The resolution highlights the adverse effects of these practices on vulnerable populations in Louisiana, including seniors, low-income families, and individuals with chronic health conditions, and emphasizes the state's commitment to improving access to affordable healthcare.

The resolution urges Congress to implement measures that would increase transparency in PBM operations, ensure that savings from negotiated rebates are passed on to consumers, regulate anti-competitive behaviors, enhance oversight of PBM practices, and hold PBMs accountable for any harm caused to patients. It calls for Louisiana's congressional delegation to advocate for reforms that protect the interests of the state's residents and contribute to national policy changes aimed at mitigating the harmful effects of PBM practices. A copy of the resolution will be sent to relevant congressional leaders and Louisiana's congressional delegation to encourage their support for these initiatives.